2021.03.31 Press release

--To the press -

FRONTEO and Advanced Media start joint research

Combining natural language analysis AI and speech recognition technology, aiming to improve the function of medical AI in the field of dementia diagnosis support

FRONTEO Inc.
Masahiro Morimoto, President and CEO
東京 都 港区 港 南 2-12-23
(Code number: 2158 TSE Mothers)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) and Advanced Media, Inc. (Headquarters: Toyoshima-ku, Tokyo, President and CEO: Kiyoyuki Suzuki, hereinafter Advanced Media) Has started joint research toward the development of medical AI software in the area of ​​dementia diagnosis support.


 In March 2021, FRONTEO submitted a clinical trial report for the "Conversational Dementia Diagnosis Support AI System" to the Pharmaceuticals and Medical Devices Agency (PMDA), aiming to obtain regulatory approval as the world's first language-based AI medical device. It is working.In this system, AI analyzes daily conversations between doctors, clinical psychologists, and other medical professionals and patients for about 3 to 5 minutes to screen for cognitive impairment and support doctors in diagnosing dementia. Thing.In the future, we believe that usability in the medical field will be further improved by advancing development so that voice data can be analyzed directly, and we are proceeding with further function expansion.

 

 Since its founding in 1997, Advanced Media has been developing various solution software centered on the voice recognition technology AmiVoice, and has created the domestic voice recognition market.We have developed and own a large number of voice recognition engines specialized for each business area, and in the medical field, we are proud of the introduction record of more than 14,000 facilities, centering on the voice input system specialized for each clinical department.

 

 In this collaboration, FRONTEO's conversational dementia diagnosis support AI system will be combined with Advanced Media's voice recognition technology to improve the practicality of the system and promote its widespread use in the medical field.

 

 FRONTEO and Advanced Media will contribute to the countermeasures against dementia, which is a socially important issue in Japan, which has reached a super-aging society, through the development and provision of effective AI solutions and AI medical devices.

 

■ About conversational dementia diagnosis support AI system
URL: https://lifescience.fronteo.com/aidevice/dementia/
The conversational dementia diagnosis support AI system (AI medical device) uses FRONTEO's original natural language analysis AI "Concept Encoder (registered trademark: conceptencoder, reading: concept encoder)" from 5 to between the patient and the doctor. It is a system that can screen for cognitive dysfunction from daily conversation for about 10 minutes.We believe that this system can contribute to the progress of digital medical care such as telemedicine and the efficiency and standardization of medical care, in addition to measures against dementia, which is an important issue in Japan, which is facing a super-aging society. I will. FRONTEO entered into a business alliance agreement with Kyowa Pharmaceutical Industry Co., Ltd., which aims to become a CNS (central nervous system) total solution company, in June 2020, aiming for early commercialization and early market penetration in the medical field.Patent registration number: Patent No. 6

 

■ AmiVoice  URL: https://www.advanced-media.co.jp/products
Voice recognition technology AmiVoice is different from conventional machine-based voice recognition, and when a person speaks to a machine naturally, it responds and records like a human being, focusing on voice recognition. It is an intelligent human interface.In addition to medical care, it is used in various fields such as minutes / transcription, call centers, development tools / mobile apps, manufacturing / logistics / distribution, daily business reports / reporting, construction / real estate, AI dialogue, and microphone devices.

 

■ About Concept Encoder
URL: https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder (registered trademark: concept encoder, reading: concept encoder)" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. "Concept Encoder" can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

 

FRONTEO  URL: https://www.fronteo.com/
FRONTEO uses the in-house developed AI engine "KIBIT" and "concept encoder" specializing in natural language processing to extract meaningful and important information from a huge amount of text data to support corporate business. A data analysis company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support international litigation of companies. Has been deployed.Based on the AI ​​technology cultivated in the legal tech business, we expanded the business field to the life science field, business intelligence field, and OSINT from 8, and created by using AI to "turn text data into knowledge". We contribute to solving various corporate issues such as drug support, dementia diagnosis support, financial, human resources, and sales support. Listed on TSE Mothers on June 2014, 2007. January 6, 26 Obtained a first-class medical device manufacturing and sales license (permit number: 2021B1X13).The capital is 13 thousand yen (as of March 1, 10350).

 

■ About Advanced Media, Inc. URL: https://www.advanced-media.co.jp/
Advanced Media, Inc. develops services in three forms centered on voice recognition technology, aiming to realize natural communication between humans and machines and to create a prosperous future.
・ "Solution business" that plans, designs, and develops voice recognition solutions that incorporate AmiVoice
・ "Product business" that licenses and sells application products incorporating AmiVoice
・ "Service business" that provides AmiVoice to users and general consumers in the company in the form of service usage


* FRONTEO, KIBIT, and concept encoder are registered trademarks of FRONTEO in Japan.
* AmiVoice® and the logo mark are registered trademarks of Advanced Media.

<Contact information for the press>
Public Relations Officer, FRONTEO Inc. Segawa
E-mail: pr_contact@fronteo.com

 

Advanced Media, Inc. Public Relations / IR Group
TEL: 03-5958-1307 Email: press@advanced-media.co.jp

 

<Inquiries regarding FRONTEO Life Science AI Business>
FRONTEO Inc. Life Science AI Business Headquarters
https://lifescience.fronteo.com/contact

ja 日本語
Machine Translation by Google. : close x